Zimbabwe has turned down a significant American health deal valued at 367 million US dollars (272 million pounds) spanning five years because of the United States' request for sensitive biological samples.
This rejection came to light after a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa believed the deal was "unbalanced".
A government spokesman has since explained that the United States was requesting health data for research and commercial gain while was not willing to guarantee the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate process of winding down our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had provided over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for more talks to secure a agreement suitable to both sides so the country's critical HIV programme can proceed.
Broader Background
This development follows a comparable situation in neighbouring Kenya, where a court blocked a similar deal with the US after legal challenges were filed about the safety of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump stated its spending was "inefficient" and his government was pursuing government-to-government agreements to boost transparency and accountability.
According to statements, 16 nations in Africa have to date agreed to these new agreements, constituting more than $18.3bn in new funding.
Details of the Declined Deal
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership would have delivered significant advantages for the people of Zimbabwe, particularly the 1.2 million currently on HIV treatment via US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to provide its genetic material and health information indefinitely, with no corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"Put simply, our country would provide the raw materials for medical research without any assurance that the final treatments would be available to our citizens if a future disease outbreak arise."
National Interest and International Frameworks
He also pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were undermining frameworks already established through the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.
"This framework is designed to guarantee that when a nation provides its information, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the resources to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We are open to ongoing discussions with our US partners on how future co-operation could be designed in a way that honours the sovereignty and interests of both nations."
Health Experts Reaction
A leading public health body expressed it recognised the official position, but recommended that talks need to persist given that a large portion of the country's HIV programmes depended on international support.
"In cases where technical issues exist, including those relating to data governance or implementation frameworks, these can frequently be addressed via detailed discussion and negotiated safeguards," it added.
This impasse highlights the continuing tensions between accepting vital foreign assistance and safeguarding a country's data in an increasingly interconnected world.